Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT : an atlas
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology..
The impact of modern imaging in uncovering the underlying pathology of PMR cannot be understated. Long dismissed as an inflammatory syndrome with links to the large vessel vasculitis giant cell arteritis (GCA), a pathognomonic pattern of musculotendinous inflammation is now attributed to PMR and may be used to confirm its diagnosis. Among the available modalities, 18F-fluorodeoxyglucose (18F-FDG) PET/CT is increasingly recognized for its high sensitivity and specificity, as well as added ability to detect concomitant large vessel GCA and exclude other relevant differentials like infection and malignancy. This atlas provides a contemporary depiction of PMR's pathology and outlines how this knowledge translates into a pattern of findings on whole body 18F-FDG PET/CT that can reliably confirm its diagnosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Rheumatology advances in practice - 8(2024), 1 vom: 12., Seite rkae003 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Owen, Claire E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diagnosis |
|---|
| Anmerkungen: |
Date Revised 21.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/rap/rkae003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368655865 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368655865 | ||
| 003 | DE-627 | ||
| 005 | 20240222092127.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240220s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/rap/rkae003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1301.xml |
| 035 | |a (DE-627)NLM368655865 | ||
| 035 | |a (NLM)38375531 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Owen, Claire E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT |b an atlas |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. | ||
| 520 | |a The impact of modern imaging in uncovering the underlying pathology of PMR cannot be understated. Long dismissed as an inflammatory syndrome with links to the large vessel vasculitis giant cell arteritis (GCA), a pathognomonic pattern of musculotendinous inflammation is now attributed to PMR and may be used to confirm its diagnosis. Among the available modalities, 18F-fluorodeoxyglucose (18F-FDG) PET/CT is increasingly recognized for its high sensitivity and specificity, as well as added ability to detect concomitant large vessel GCA and exclude other relevant differentials like infection and malignancy. This atlas provides a contemporary depiction of PMR's pathology and outlines how this knowledge translates into a pattern of findings on whole body 18F-FDG PET/CT that can reliably confirm its diagnosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a imaging | |
| 650 | 4 | |a pathology | |
| 650 | 4 | |a polymyalgia rheumatica | |
| 650 | 4 | |a whole-body positron emission tomography/computed tomography | |
| 700 | 1 | |a Poon, Aurora M T |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Bonnia |e verfasserin |4 aut | |
| 700 | 1 | |a Liew, David F L |e verfasserin |4 aut | |
| 700 | 1 | |a Yap, Lee Pheng |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Victor |e verfasserin |4 aut | |
| 700 | 1 | |a Leung, Jessica L |e verfasserin |4 aut | |
| 700 | 1 | |a McMaster, Christopher R |e verfasserin |4 aut | |
| 700 | 1 | |a Scott, Andrew M |e verfasserin |4 aut | |
| 700 | 1 | |a Buchanan, Russell R C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology advances in practice |d 2017 |g 8(2024), 1 vom: 12., Seite rkae003 |w (DE-627)NLM291368786 |x 2514-1775 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:1 |g day:12 |g pages:rkae003 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/rap/rkae003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 1 |b 12 |h rkae003 | ||